Saturday, July 5, 2025
HomeIndustriesBiotechnology

Biotechnology

ImmVira Enters Clinical Development in Combination Therapy of MVR-T3011 IT and MEK Inhibitor in the U.S.

ImmVira announced that, company has reached a cooperation agreement with Roche to establish clinical research partnership recently, to conduct clinical studies in the U.S....

Consegna Pharma Acquires Fathom Pharma to Strengthen Initiatives that Address the Opioid Crisis

Consegna Pharma Inc., a drug delivery company providing solutions to reduce deaths from opioid overdoses, is pleased to announce the acquisition of Fathom Pharma...

SNIPR BIOME Initiates First-in-Human Clinical Trial with SNIPR001

SNIPR BIOME ApS, a leading CRISPR and microbiome gene therapy biotechnology company, announced dosing of the first human subjects in its phase 1 clinical...

FDA Granted CMG901 Fast Track Designation for Unresectable or Metastatic Gastric and Gastroesophageal Junction Cancer

Keymed Biosciences announced that the U.S. Food and Drug Administration (FDA) granted CMG901 Fast Track Designation as monotherapy for the treatment of unresectable or...

Eiger BioPharmaceuticals Strengthens Leadership Team with New Executive Appointments

Eiger BioPharmaceuticals, Inc. a commercial-stage biopharmaceutical company focused on the development of innovative therapies to treat and cure Hepatitis Delta Virus (HDV) and other...
0FansLike
0FollowersFollow
spot_img

Hot Topics